| 4E-BP1 | eukaryotic translation initiation factor 4E binding protein 1 |
| ARID1A | AT rich interactive domain 1A |
| ATP | adenosine triphosphate |
| CD3ε | T-cell surface glycoprotein CD3 epsilon chain |
| CPPSML | PB-Cre+ PtenL/L p53L/L Smad4L/L mTmGL/+ LSL-LucL/+ |
| CRPC | castration-resistant prostate cancer |
| Csk | C-terminal Src kinase |
| CTL | cytotoxic T lymphocyte |
| CTLA4 | cytotoxic-T-lymphocyte-associated protein 4 |
| eIF4G | eukaryotic translation initiation factor 4G |
| FACS | fluorescence-activated cell sorting |
| Fyn | tyrosine-protein kinase Fyn |
| GO | Gene Ontology |
| Gr-MDSC | granulocytic myeloid-derived suppressor cell |
| ICB | immune checkpoint blockade |
| KEGG | Kyoto Encyclopedia of Genes and Genomes |
| Lck | lymphocyte protein tyrosine kinase |
| MACS | magnetic-activated cell sorting |
| MAPK | mitogen-activated protein kinase |
| mTOR | mechanistic target of rapamycin kinase |
| mTORC1 | mTOR Complex I |
| NDRG1 | N-myc downstream regulated gene 1 |
| PCa | prostate cancer |
| PD1 | programmed cell death 1 |
| PD-L1 | programmed cell death 1 ligand 1 |
| PI3K | phosphoinositide-3-kinase |
| PTM | post-translational modification |
| RPPA | Reverse Phase Protein Array |
| S6K1 | ribosomal protein S6 kinase |
| Src | Rous sarcoma oncogene |
| TAZ | tafazzin |
| TKi | tyrosine kinase inhibitor |
| TNF-α | tumor necrosis factor alpha |
| YAP | yes-associated protein |